Skip to content

Insider · CIK 0001776977

Julie Cooke

officer

Files at NBIX (NEUROCRINE BIOSCIENCES INC). First filing Feb 4, 2025, latest Feb 14, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $530k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NBIX: NEUROCRINE BIOSCIENCES INC

NBIXOct 9, 2026 · close 142.44

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
7Weak
NBIXsell 710b5-1
NEUROCRINE BIOSCIENCES INC
$181k
1,551 shares
-8%-
4Weak
NBIXsell 710b5-1
NEUROCRINE BIOSCIENCES INC
$83k
700 shares
-4%-
8Weak
NBIXsell 710b5-1
NEUROCRINE BIOSCIENCES INC
$266k
1,740 shares
-9%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AGrant or award
Common Stock
+3,587$0.00$025,96127 d ago
Sep 11, 2026NBIX
NEUROCRINE BIOSCIENCES INC
FTax withholding
Common Stock
-1,936$156.22$302k24,02527 d ago
May 16, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Common Stock
+6,468$61.82$400k26,858May 20, 2025
May 16, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Incentive Stock Optionderivative
-6,468$0.00$00May 20, 2025
Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,509$0.00$020,340Feb 14, 2025
Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-796$116.77$93k19,544Feb 14, 2025
Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,401$0.00$020,945Feb 14, 2025
Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-755$116.80$88k20,190Feb 14, 2025
Feb 12, 2025NBIX
NEUROCRINE BIOSCIENCES INC
AGrant or award
Stock Optionderivative10b5-1
+29,600$0.00$029,600Feb 14, 2025
Feb 12, 2025NBIX
NEUROCRINE BIOSCIENCES INC
AGrant or award
Restricted Stock Unitderivative10b5-1
+5,548$0.00$05,548Feb 14, 2025
Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitderivative10b5-1
-1,509$0.00$03,020Feb 14, 2025
Feb 13, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitderivative10b5-1
-1,401$0.00$04,203Feb 14, 2025
Feb 8, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,329$0.00$019,531Feb 12, 2025
Feb 10, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-700$118.28$83k18,831Feb 12, 2025
Feb 8, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitderivative10b5-1
-1,329$0.00$00Feb 12, 2025
Jan 31, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,740$0.00$019,942Feb 4, 2025
Jan 31, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-916$152.89$140k19,026Feb 4, 2025
Jan 31, 2025NBIX
NEUROCRINE BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-824$152.89$126k18,202Feb 4, 2025
Jan 31, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitderivative10b5-1
-1,740$0.00$01,741Feb 4, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Julie Cooke: insider trades and track record | InsiderTell